HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hatch Question, Gottlieb Response Speak Volumes About DSHEA Reliance

This article was originally published in The Rose Sheet

Executive Summary

Gottlieb is not the first FDA commissioner nominee to profess support for its regulatory framework established by DSHEA, but the focus of Hatch's question serves stronger notice than similar questions asked of previous candidates that the agency authority to enforce in the space does need adjustment.

Advertisement

Related Content

FDA Review Of Dietary Ingredients For Pharmacy Compounding Could Open Door To Change DSHEA
Canada Tilts At Unneeded Fixes In Self-Care Product Regulation Overhaul – Industry
Industry Eyes NDI Notification Common Ground With Gottlieb-Led FDA
Gottlieb Recognizes OTC Monograph Woes During Confirmation Hearing
Supplement Pre-market Approval Resurfaces From Blumenthal, Durbin

Topics

Advertisement
UsernamePublicRestriction

Register

RS109218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel